Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05665348
Title Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy (TRIPLET)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Federation Francophone de Cancerologie Digestive
Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.